印刷

診療科・部門紹介
診療科・部門紹介

肝・胆・膵外科

肝・胆・膵外科

最終更新日 : 2021年3月23日

診療科の特徴診療実績スタッフ紹介|業績紹介

研究実績・論文発表

2015年

◆Anatomical Liver Resections Guided by 3-Dimensional Parenchymal Staining Using Fusion Indocyanine Green Fluorescence Imaging.
Inoue Y, Arita J, Sakamoto T, Ono Y, Takahashi M, Takahashi Y, Kokudo N, Saiura A.
Ann Surg. 2015 Jul;262(1):105-11.

◆Favorable outcome after repeat resection for colorectal liver metastases.
Saiura A, Yamamoto J, Koga R, Takahashi Y, Takahashi M, Inoue Y, Ono Y, Kokudo N.
Ann Surg Oncol. 2014 Dec;21(13):4293-9.

◆Hepatic Vein-Oriented Liver Resection Using Fusion Indocyanine Green Fluorescence Imaging.
Inoue Y, Saiura A, Arita J, Takahashi Y.
Ann Surg. 2015 Dec;262(6):e98-9.

◆Prognostic value of neutrophil-lymphocyte ratio and level of C-reactive protein in a large cohort of pancreatic cancer patients: a retrospective study in a single institute in Japan.
Inoue D, Ozaka M, Matsuyama M, Yamada I, Takano K, Saiura A, Ishii H.
Jpn J Clin Oncol. 2015 Jan;45(1):61-6

◆Sinistral portal hypertension after pancreaticoduodenectomy with splenic vein ligation.
Ono Y, Matsueda K, Koga R, Takahashi Y, Arita J, Takahashi M, Inoue Y, Unno T, Saiura A.
Br J Surg. 2015 Feb;102(3):219-28.

◆Pancreatoduodenectomy With Systematic Mesopancreas Dissection Using a Supracolic Anterior Artery-first Approach.
Inoue Y, Saiura A, Yoshioka R, Ono Y, Takahashi M, Arita J, Takahashi Y, Koga R.
Ann Surg. 2015 Dec;262(6):1092-101.

◆Routine Preoperative Liver-specific Magnetic Resonance Imaging Does Not Exclude the Necessity of Contrast-enhanced Intraoperative Ultrasound in Hepatic Resection for Colorectal Liver Metastasis.
Arita J, Ono Y, Takahashi M, Inoue Y, Takahashi Y, Matsueda K, Saiura A.
Ann Surg. 2015 Dec;262(6):1086-91.

◆【局所進行膵癌における血管合併切除】 Borderline膵癌に対する門脈脾静脈合併切除を伴う結腸上前方アプローチによる膵頭十二指腸切除
井上 陽介(がん研有明病院 消化器外科), 石沢 武彰, 高橋 祐, 齋浦 明夫
手術 (0037-4423)69巻2号 Page125-133

◆【肝胆膵イメージング:画像が映す分子病理】 肝疾患 ICG蛍光イメージングの分子メカニズムと臨床応用
石沢 武彰(がん研有明病院 消化器外科), 齋浦 明夫
肝・胆・膵 (0389-4991)70巻4号 Page567-572

◆【最新臨床大腸癌学-基礎研究から臨床応用へ-】 大腸癌の検査・診断 転移・再発巣の診断 大腸癌肝転移の画像診断・概論
齋浦 明夫(がん研有明病院 消化器外科), 有田 淳一, 高橋 祐, 井上 陽介, 石沢 武彰
日本臨床 (0047-1852)73巻増刊4 最新臨床大腸癌学 Page308-313

 

2016年

◆Delayed Gastric Emptying After Stapled Versus Hand-Sewn Anastomosis of Duodenojejunostomy in Pylorus-Preserving Pancreaticoduodenectomy: a Randomized Controlled trial.
Sakamoto Y, Hori S, Oguro S, Arita J, Kishi Y, Nara S, Esaki M, Saiura A, Shimada K, Yamanaka T, Kosuge T. J Gastrointest Surg. 2016 Mar;20(3):595-603.

◆Laparoscopic deroofing for polycystic liver disease using laparoscopic fusion indocyanine green fluorescence imaging.
Tanaka M, Inoue Y, Mise Y, Ishizawa T, Arita J, Takahashi Y, Saiura A.
Surg Endosc. 2015 Sep 28.

◆Wide Applicability and Various Advantages of Supracolic Anterior Artery-first Approach in Pancreatoduodenectomy.
Inoue Y, Saiura A, Ishizawa T, Takahashi Y.
Ann Surg. 2015 Nov 10.

◆High Rate of Organ/Space Surgical Site Infection After Hepatectomy with Preexisting Bilioenteric Anastomosis.
Matsumura M, Saiura A, Inoue Y, Ishizawa T, Mise Y, Takahashi Y.
World J Surg. 2016 Apr;40(4):937-45.

◆A case of inflammatory hepatocellular adenoma displaying an unusual histological pattern.
Kanda H, Furuta R, Motoi N, Kakita T, Sugiura Y, Unno T, Matsueda K, Saiura A, Sugitani M, Ishikawa Y.
Clin J Gastroenterol. 2015 Dec;8(6):426-34.

◆Distal Pancreatectomy with En Bloc Resection of the Celiac Axis with Preservation or Reconstruction of the Left Gastric Artery in Patients with Pancreatic Body Cancer.
Sato T, Saiura A, Inoue Y, Takahashi Y, Arita J, Takemura N.
World J Surg. 2016 May 19.

◆Parenchymal-Sparing Hepatectomy Does Not Increase Intrahepatic Recurrence in Patients with Advanced Colorectal Liver Metastases.
Matsumura M, Mise Y, Saiura A, Inoue Y, Ishizawa T, Ichida H, Matsuki R, Tanaka M, Takeda Y, Takahashi Y.
Ann Surg Oncol. 2016 May 20.

Parenchymal-sparing hepatectomy for deep-placed colorectal liver metastases.
Matsuki R, Mise Y, Saiura A, Inoue Y, Ishizawa T, Takahashi Y.
Surgery. 2016 Nov;160(5):1256-1263. 

Adjuvant Oral Uracil-Tegafur with Leucovorin for Colorectal Cancer Liver Metastases: A Randomized Controlled Trial.
Hasegawa K, Saiura A, Takayama T, Miyagawa S, Yamamoto J, Ijichi M, Teruya M, Yoshimi F, Kawasaki S, Koyama H, Oba M, Takahashi M, Mizunuma N, Matsuyama Y, Watanabe T, Makuuchi M, Kokudo N.
PLoS One. 2016 Sep 2;11(9):e0162400. 

Clinical application of indocyanine green-fluorescence imaging during hepatectomy.
Ishizawa T, Saiura A, Kokudo N.
Hepatobiliary Surg Nutr. 2016 Aug;5(4):322-8. 

Technical Details of an Anterior Approach to the Superior Mesenteric Artery During Pancreaticoduodenectomy.
Inoue Y, Saiura A, Tanaka M, Matsumura M, Takeda Y, Mise Y, Ishizawa T, Takahashi Y.
J Gastrointest Surg. 2016 Oct;20(10):1769-77. 

Outcomes after resection of occupational cholangiocarcinoma.
Kubo S, Takemura S, Tanaka S, Shinkawa H, Kinoshita M, Hamano G, Ito T, Koda M, Aota T, Yamamoto T, Terajima H, Tachiyama G, Yamada T, Nakamori S, Arimoto A, Fujikawa M, Tomimaru Y, Sugawara Y, Nakagawa K, Unno M, Mizuguchi T, Takenaka K, Kimura K, Shirabe K, Saiura A, Uesaka K, Taniguchi H, Fukuda A, Chong JM, Kuwae Y, Ohsawa M, Sato Y, Nakanuma Y.
J Hepatobiliary Pancreat Sci. 2016 Sep;23(9):556-64.

Laparoscopic pancreatoduodenectomy combined with a novel self-assessment system and feedback discussion: a phase 1 surgical trial following the IDEAL guidelines.
Inoue Y, Saiura A, Sato T, Ishizawa T, Arita J, Takahashi Y, Hiki N, Sano T, Yamaguchi T.
Langenbecks Arch Surg. 2016 Dec;401(8):1123-1130. 

Phase 1 study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases.
Takahashi M, Hasegawa K, Oba M, Saiura A, Arita J, Sakamoto Y, Shinozaki E, Mizunuma N, Matsuyama Y, Kokudo N.
Invest New Drugs. 2016 Aug;34(4):468-73.

RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomy.
Osumi H, Shinozaki E, Suenaga M, Matsusaka S, Konishi T, Akiyoshi T, Fujimoto Y, Nagayama S, Fukunaga Y, Ueno M, Mise Y, Ishizawa T, Inoue Y, Takahashi Y, Saiura A, Uehara H, Mun M, Okumura S, Mizunuma N, Miki Y, Yamaguchi T.
Int J Cancer. 2016 Aug 15;139(4):803-11.

Touch cytology smear of an inflammatory hepatocellular adenoma displaying an unusual pattern: A case report.
Kanda H, Furuta R, Motoi N, Suzuki N, Furuta N, Komatsu K, Sugiyama Y, Saiura A, Sugitani M, Ishikawa Y.
Diagn Cytopathol. 2016 Dec;44(12):1074-1077.

◆【看護の理由が見える 主要術式イラスト便利帳】 肝葉切除術/肝区域切除術
齋浦 明夫(がん研究会有明病院 肝胆膵外科)
消化器外科Nursing (1341-7819)21巻1号 Page24-26

◆手術手技 膵頭十二指腸切除術における脾静脈合併切除の検討
田中 真之(がん研究会有明病院 消化器外科), 三瀬 祥弘, 石沢 武彰, 井上 陽介, 高橋 祐, 齋浦 明夫
手術 (0037-4423)70巻3号 Page323-330

◆【最新の肝胆膵画像シミュレーション】 開腹・鏡視下肝胆膵手術における蛍光イメージングの応用
石沢 武彰(がん研究会有明病院 消化器外科), 齋浦 明夫
消化器外科 (0387-2645)39巻1号 Page31-36

【最新の画像支援に基づく肝胆膵手術】 ICG蛍光イメージングの臨床応用(解説/特集)
寺澤 無我(がん研究会有明病院 消化器外科), 石沢 武彰井上 陽介三瀬 祥弘高橋 祐齋浦 明夫
 手術 (0037-4423)70巻2号 Page163-168(2016.02)

【最新 肝胆膵高難度外科手術アトラス】 高難度外科手術手技 膵臓 膵頭部癌の膵頭十二指腸切除における門脈合併切除・再建(図説/特集)
田中 真之(がん研究会有明病院 消化器外科), 三瀬 祥弘石沢 武彰井上 陽介高橋 祐齋浦 明夫
 手術 (0037-4423)70巻4号 Page545-554(2016.03)

【イラストで学ぶ消化器外科再建法のすべて】 胆道 胆道再建 胆管空腸吻合(図説/特集)
高橋 祐(がん研究会有明病院 消化器外科), 井上 陽介石沢 武彰三瀬 祥弘齋浦 明夫
 外科 (0016-593X)78巻12号 Page1417-1423(2016.11)

【術前内視鏡】 早期十二指腸癌に対する治療方針と術前内視鏡検査(解説/特集)
寺澤 無我(がん研究会有明病院 消化器外科), 三瀬 祥弘山本 頼正齋浦 明夫
消化器内視鏡 (0915-3217)28巻12号 Page1967-1971(2016.12)

2017

◆Use of intercostal trocars for laparoscopic resection of subphrenic hepatic tumors.
Ichida H, Ishizawa T, Tanaka M, Terasawa M, Watanabe G, Takeda Y, Matsuki R, Matsumura M, Hata T, Mise Y, Inoue Y, Takahashi Y, Saiura A.
Surg Endosc. 2017 Mar;31(3):1280-1286.

◆Risk Factors for and Management of Postpancreatectomy Hepatic Steatosis.
Takemura N, Saiura A, Koga R, Yamamoto J, Yamaguchi T.
Scand J Surg. 2017 Sep;106(3):224-229.

◆Distal Pancreatectomy with Celiac Axis Resection Combined with Reconstruction of the Left Gastric Artery.
Sato T, Inoue Y, Takahashi Y, Mise Y, Ishizawa T, Tanakura K, Ito H, Saiura A.
J Gastrointest Surg. 2017 May;21(5):910-917.

◆Index of convexity: A novel method for assessing liver functional reserve using technetium-99m-galactosyl human serum albumin liver scintigraphy.
Sato T, Arita J, Inoue Y, Koga R, Takahashi Y, Saiura A.
Biosci Trends. 2017 Jul 24;11(3):333-339.

◆Wide Applicability and Various Advantages of Supracolic Anterior Artery-first Approach in Pancreatoduodenectomy.
Inoue Y, Saiura A, Ishizawa T, Takahashi Y.
Ann Surg. 2017 Jun;265(6):E82-E83.

◆Repermeabilized Umbilical Vein of the Round Ligament for Hepatobiliary
Malignancies.
Takahashi M, Saiura A, Takahashi Y. The Usefulness of Patch Repair Using the
World J Surg. 2017 Nov;41(11):2813-2816.

◆Optimal Lymphadenectomy for Duodenal Adenocarcinoma: Does the Number Alone Matter?
Sakamoto T, Saiura A, Ono Y, Mise Y, Inoue Y, Ishizawa T, Takahashi Y, Ito H.
Ann Surg Oncol. 2017 Oct;24(11):3368-3375.

◆Applications of fusion-fluorescence imaging using indocyanine green in laparoscopic hepatectomy.
Terasawa M, Ishizawa T, Mise Y, Inoue Y, Ito H, Takahashi Y, Saiura A.
Surg Endosc. 2017 Dec;31(12):5111-5118.

◆Asymptomatic Pancreatic Cancer: Does Incidental Detection Impact Long-Term Outcomes?
Takeda Y, Saiura A, Takahashi Y, Inoue Y, Ishizawa T, Mise Y, Matsumura M, Ichida H, Matsuki R, Tanaka M, Ito H.
J Gastrointest Surg. 2017 Aug;21(8):1287-1295.

◆Short-Term Outcomes after Simultaneous Colorectal and Major Hepatic Resection for Synchronous Colorectal Liver Metastases.
Ono Y, Saiura A, Arita J, Takahashi Y, Takahashi M, Inoue Y.
Dig Surg. 2017;34(6):447-454.

◆Role of surgical resection for non-colorectal non-neuroendocrine liver metastases.
Takemura N, Saiura A.
World J Hepatol. 2017 Feb 18;9(5):242-251.

Feasibility of Intraoperative Navigation for Liver Resection Using Real-time Virtual Sonography With Novel Automatic Registration System.
Takamoto T, Mise Y, Satou S, Kobayashi Y, Miura K, Saiura A, Hasegawa K, Kokudo N, Makuuchi M.
World J Surg. 2017 Sep 6

Pretreatment Serum Carbohydrate Antigen 19-9 Concentration Is a Predictor of Survival of Patients Who Have Undergone Curative Resection of Stage IV Rectal Cancer.
Miki H, Akiyoshi T, Ogura A, Nagasaki T, Konishi T, Fujimoto Y, Nagayama S, Noma H, Saiura A, Fukunaga Y, Ueno M.
Dig Surg. 2017 Sep 1.

Tankyrase-Binding Protein TNKS1BP1 Regulates Actin Cytoskeleton Rearrangement and Cancer Cell Invasion.
Ohishi T, Yoshida H, Katori M, Migita T, Muramatsu Y, Miyake M, Ishikawa Y, Saiura A, Iemura SI, Natsume T, Seimiya H.
Cancer Res. 2017 May 1;77(9):2328-2338.

IPMNIPNB IPMNの術前画像診断(解説/特集)
井上 陽介(がん研究会有明病院 消化器外科), 齋浦 明夫
 外科 (0016-593X)78巻11号 Page1150-1156(2016.11)

【膵癌への挑戦】 膵癌に対するより根治度の高い膵切除術とは(解説/特集)
井上 陽介(がん研究会有明病院 消化器外科), 齋浦 明夫
Pharma Medica (0289-5803)35巻1号 Page39-45(2017.01)

【消化器癌手術に必要な拡大視による局所微細解剖アトラス】 Hepato-Biliary-Pancreatic Surgery Central vascular ligationに基づいたSMA周囲郭清(図説/特集)
井上 陽介(がん研究会有明病院 消化器外科), 齋浦 明夫
手術 (0037-4423)71巻4号 Page673-684(2017.03)

【百花繚乱!エネルギーデバイスを使いこなす】術式別 デバイスの選択と活用法 膵頭十二指腸切除術(解説/特集)
井上 陽介(がん研究会有明病院 消化器外科), 齋浦 明夫
臨床外科 (0386-9857)72巻5号 Page597-603(2017.05)

膵癌手術におけるリンパ節・神経叢郭清の意義とベストプラクティス 過不足のないリンパ節・神経叢郭清と、早期の回復を担保したR0切除がベスト(Q&A)
齋浦 明夫(がん研究会有明病院 消化器外科), 赤松 延久
日本医事新報 (0385-9215)4857号 Page57(2017.05)

外科医が知っておくべきpivotal study[4] 膵頭部癌に対する膵頭十二指腸切除,標準郭清と拡大郭清の無作為比較試験(解説)
高橋 祐(がん研究会有明病院 消化器外科), 齋浦 明夫
外科 (0016-593X)79巻6号 Page559-563(2017.06)

小型膵神経内分泌腫瘍の切除適応 【1cm以下の早期濃染される膵腫瘤は経過観察可】(Q&A)
岸 庸二(国立がん研究センター中央病院 肝胆膵外科), 齋浦 明夫
日本医事新報 (0385-9215)4861号 Page55-56(2017.06)
                                                                                                                            
【混合型肝癌をめぐる混乱の終焉を目指して】 混合型肝癌[ICD-0 code 8180/3(WHO2010)]の画像診断(解説/特集)
上田 和彦(がん研究会有明病院 画像診断部), 平塚 真生子松枝 清高澤 豊笹平 直樹齋浦 明夫田中 榮司宮川 眞一
肝・胆・膵 (0389-4991)74巻5号 Page761-767(2017.05)

【膵癌術前診断・治療の新展開】 膵癌切除可能性と術式決定に必要な画像診断(解説/特集)
水野 智哉(がん研究会有明病院 消化器外科), 齋浦 明夫
消化器・肝臓内科 (2432-3446)1巻6号 Page586-592(2017.06)

FOCUS 消化器外科における蛍光ガイド手術の可能性 肝胆道領域への臨床応用(解説)
入江 彰一(がん研究会有明病院 消化器外科), 石沢 武彰齋浦 明夫
臨床外科 (0386-9857)72巻12号 Page1365-1370(2017.11)

【急性胆嚢炎に対する最新のマネージメント】 蛍光イメージング下胆嚢摘出術の実際とコツ(解説/特集)
石沢 武彰(がん研究会有明病院 消化器外科), 中瀬古 裕一齋浦 明夫
胆と膵 (0388-9408)38巻10号 Page1187-1191(2017.10)

2018

◆Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer. 
Inamura K, Takazawa Y, Inoue Y, Yokouchi Y, Kobayashi M, Saiura A, et al.
Journal of clinical medicine. 2018;7(7).

◆Optimal Extent of Superior Mesenteric Artery Dissection during Pancreaticoduodenectomy for Pancreatic Cancer: Balancing Surgical and Oncological Safety.        
Inoue Y, Saiura A, Oba A, Kawakatsu S, Ono Y, Sato T, et al.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2018.

◆A Novel Classification and Staged Approach for Dissection Along the Celiac and Hepatic Artery During Pancreaticoduodenectomy.      
Inoue Y, Saiura A, Takahashi Y.
World journal of surgery. 2018;42(9):2963-7.

◆Fluorescence Imaging for Minimally Invasive Cancer Surgery.
Ishizawa T, Saiura A.
Surgical oncology clinics of North America. 2019;28(1):45-60.

◆Comparison of pancreatojejunostomy techniques in patients with a soft pancreas: Kakita anastomosis and Blumgart anastomosis.
Kawakatsu S, Inoue Y, Mise Y, Ishizawa T, Ito H, Takahashi Y, et al.
BMC surgery. 2018;18(1):88.

◆Response of the Authors to the Letter of the Editor Surgical Anatomy of the Superior Mesenteric Vessels Related to Pancreaticoduodenectomy: a Systematic Review and Meta-Analysis.  
Negoi I, Beuran M, Hostiuc S, Negoi RI, Inoue Y.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2018;22(8):1457.

◆Surgical Anatomy of the Superior Mesenteric Vessels Related to Colon and Pancreatic Surgery: A Systematic Review and Meta-Analysis.
Negoi I, Beuran M, Hostiuc S, Negoi RI, Inoue Y.
Scientific reports. 2018;8(1):4184.

◆Surgical Anatomy of the Superior Mesenteric Vessels Related to Pancreaticoduodenectomy: a Systematic Review and Meta-Analysis.
Negoi I, Beuran M, Hostiuc S, Negoi RI, Inoue Y.
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2018;22(5):802-17.

◆Impact of indocyanine green-fluorescence imaging on distal pancreatectomy with celiac axis resection combined with reconstruction of the left gastric artery.
Oba A, Inoue Y, Sato T, Ono Y, Mise Y, Ito H, et al.
HPB : the official journal of the International Hepato Pancreato Biliary Association. 2018.

◆Clinical implications of disappearing colorectal liver metastases have changed in the era of hepatocyte-specific MRI and contrast-enhanced intraoperative ultrasonography.
Oba A, Mise Y, Ito H, Hiratsuka M, Inoue Y, Ishizawa T, et al.
HPB : the official journal of the International Hepato Pancreato Biliary Association. 2018;20(8):708-14.

◆Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.
Shigematsu Y, Inamura K, Yamamoto N, Mise Y, Saiura A, Ishikawa Y, et al.
BMC cancer. 2018;18(1):980.

◆Hepatic Eosinophilic Abscess Associated with Sigmoid Colon Cancer.
Shigematsu Y, Kanda H, Nagasaki T, Ishizawa T, Inoue Y, Takahashi S.
Internal medicine (Tokyo, Japan). 2018;57(10):1405-9.

◆Feasibility of Intraoperative Navigation for Liver Resection Using Real-time Virtual Sonography With Novel Automatic Registration System.
Takamoto T, Mise Y, Satou S, Kobayashi Y, Miura K, Saiura A, et al.
World journal of surgery. 2018;42(3):841-8.

●【胆管癌の手術】遠位側胆管癌に対する膵頭十二指腸切除. 
高橋 祐, 齋浦 明夫.
手術. 2018;72(10):1499-507.

●【徹底解説!-膵頭十二指腸切除の手術手技】手術手技 上腸間膜動脈・腹腔動脈 肝動脈周囲神経,リンパ節郭清の実際. 
渡邉 元己, 井上 陽介, 三瀬 祥弘, 石沢 武彰, 伊藤 寛倫, 高橋 祐, et al.
【臨床外科. 2018;73(3):280-5.

●【胆道・膵疾患術後の晩期障害】 膵癌に対する脾静脈合併切除を伴う膵頭十二指腸切除後の左側門脈圧亢進症. 
小野 嘉大, 井上 陽介, 田中 真之, 佐藤 崇文, 高橋 祐, 三瀬 祥弘, et al.
胆と膵. 2018;39(5):435-41.

●【Borderline resectable膵癌に対する集学的治療】 Borderline resectable膵癌に対するGEM+nab-paclitaxelを用いた集学的治療の経験. 
井上 陽介, 齋浦 明夫.
癌の臨床. 2018;63(5):439-45.

2019

◆Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases. Ichida H, Mise Y, Ito H, Ishizawa T, Inoue Y, Takahashi Y, et al. World journal of surgical oncology. 2019;17(1):100.

◆Impact of portal vein resection with splenic vein reconstruction after pancreatoduodenectomy on sinistral portal hypertension: Who needs reconstruction? Tanaka M, Ito H, Ono Y, Matsueda K, Mise Y, Ishizawa T, et al. Surgery. 2019;165(2):291-7.

◆Optimal Extent of Superior Mesenteric Artery Dissection during Pancreaticoduodenectomy for Pancreatic Cancer: Balancing Surgical and Oncological Safety. Inoue Y, Saiura A, Oba A, Kawakatsu S, Ono Y, Sato T, et al. J Gastrointest Surg. 2019;23(7):1373-83.

◆Encapsulating fibrosis following neoadjuvant chemotherapy is correlated with outcomes in patients with pancreatic cancer. Matsuda Y, Inoue Y, Hiratsuka M, Kawakatsu S, Arai T, Matsueda K, et al. PloS one. 2019;14(9):e0222155.

◆Identification of a specific ultrasonographic finding for differentiating hepatic angiomyolipoma from hepatocellular carcinoma. Naito K, Shigematsu Y, Fujiwara Y, Inamura K, Togashi Y, Inoue Y, et al. Clinical imaging. 2019;59(2):104-8.

◆Left kidney mobilization technique during radical antegrade modular pancreatosplenectomy (RAMPS). Watanabe G, Ito H, Sato T, Ono Y, Mise Y, Inoue Y, et al. Langenbecks Arch Surg. 2019;404(2):247-52.

◆Impact of indocyanine green-fluorescence imaging on distal pancreatectomy with celiac axis resection combined with reconstruction of the left gastric artery. Oba A, Inoue Y, Sato T, Ono Y, Mise Y, Ito H, et al. HPB (Oxford). 2019;21(5):619-25.

◆Three-Dimensional Fixation: Pathological Protocol Following Pancreaticoduodenectomy with Portal Vein Resection for Pancreatic Cancer. Tanaka M, Inoue Y, Matsueda K, Hiratsuka M, Muto M, Kawakatsu S, et al. J Gastrointest Surg. 2019.

◆Preoperative Biliary Drainage for Patients with Perihilar Bile Duct Malignancy. Takahashi Y, Ito H, Inoue Y, Mise Y, Ono Y, Sato T, et al. J Gastrointest Surg. 2019.

◆Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons. Sanchez-Velazquez P, Muller X, Malleo G, Park JS, Hwang HK, Napoli N, Inoue Y, Saiura A, et al. Ann Surg. 2019.

◆Techniques for splenic vein reconstruction after pancreaticoduodenectomy with portal vein resection for pancreatic cancer. Ono Y, Tanaka M, Matsueda K, Hiratsuka M, Takahashi Y, Mise Y, et al. HPB (Oxford). 2019.

◆Possible underestimation of blood loss during laparoscopic hepatectomy. BJS open. Oba A, Ishizawa T, Mise Y, Inoue Y, Ito H, Ono Y, et al. 2019;3(3):336-43.

◆Left-sided Portal Hypertension After Pancreaticoduodenectomy With Resection of the Portal Vein/Superior Mesenteric Vein Confluence in Patients With Pancreatic Cancer: A Project Study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery. Mizuno S, Kato H, Yamaue H, Fujii T, Satoi S, Saiura A, Murakami Y, Sho M, Yamamoto M, Isaji S.
Ann Surg. 2019 Jul 26.

◆Fluorescence Imaging for Minimally Invasive Cancer Surgery. Ishizawa T, Saiura A. Surg Oncol Clin N Am. 2019;28(1):45-60.

●【高度進行消化器癌に対する手術】肝・胆・膵 肝静脈再建を伴う肝切除. 
三瀬 祥弘, 齋浦 明夫.
手術. 2019;73(4):531-9.

●【新 手術記録の書き方】肝臓の手術/肝細胞癌 開腹手術 肝前区域切除術. 
佐藤 崇文, 齋浦 明夫.
消化器外科. 2019;42(5):708-12.

●肝胆膵外科の臨床研究 update 2019】大腸癌肝転移に対する術前術後補助療法. 
黒木 直美, 三瀬 祥弘, 大庭 篤志, 高橋 祐, 齋浦 明夫.
【外科. 2019;81(6):629-35.

●【ICG蛍光法を用いた肝胆道外科手術】ICG蛍光法を用いた腹腔鏡下肝葉切除術. 
入江 彰一, 井上 陽介, 小野 嘉大, 佐藤 崇文, 伊藤 寛倫, 高橋 祐.
手術. 2019;73(10):1417-21.

●【門脈圧亢進症の最新情報】膵疾患と左側門脈圧亢進症 脾静脈合併切除を伴う膵頭十二指腸切除術後の左側門脈圧亢進症の病態と予防. 
田中 真之, 小野 嘉大, 井上 陽介, 高橋 祐, 三瀬 祥弘, 佐藤 崇文, et al.
外科. 2019;81(2):138-41.

●胆道癌・膵癌に対する標準手術 手技取得へのナビゲート 膵頭部癌に対する膵頭十二指腸切除術. 
小野嘉大、井上陽介、橋祐、齋浦明夫.  新DS NOW No.4. 2019, 104-135

2020年

◆Impact on operative outcomes of laparoscopic simultaneous resection of colorectal cancer and synchronous liver metastases. Kawakatsu S, Ishizawa T, Fujimoto Y, Oba A, Mise Y, Inoue Y, et al. Asian journal of endoscopic surgery. 2020.

◆Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection? Oba A, Inoue Y, Ono Y, Irie S, Sato T, Mise Y, et al. Langenbecks Arch Surg. 2020;405(1):35-41.

◆Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion. Oba A, Ito H, Ono Y, Sato T, Mise Y, Inoue Y, et al. BJS open. 2020.

◆A multicenter prospective registration study on laparoscopic pancreatectomy in Japan: report on the assessment of 1,429 patients. Ohtsuka T, Nagakawa Y, Toyama H, Takeda Y, Maeda A, Kumamoto Y, Inoue Y. et al. J Hepatobiliary Pancreat Sci. 2020;27(2):47-55.

◆Early Fistulography Can Predict Whether Biochemical Leakage Develops to Clinically Relevant Postoperative Pancreatic Fistula. Takeda Y, Saiura A, Inoue Y, Mise Y, Ishizawa T, Takahashi Y, et al. World J Surg. 2020;44(4):1252-9.

◆Repeat Hepatectomy for Early Recurrence of Colorectal Liver Metastases-Prognostic Impacts Assessed from the Recurrence Pattern. Watanabe G, Mise Y, Ito H, Inoue Y, Ishizawa T, Takahashi Y, et al. World J Surg. 2020;44(1):268-76.

◆Multidisciplinary treatment for colorectal liver metastases in elderly patients. World journal of surgical oncology. Hata T, Mise Y, Ono Y, Sato T, Inoue Y, Ito H, et al. 2020;18(1):173.

◆Clinical significance of subcentimeter pulmonary nodules in patients undergoing hepatectomy for colorectal liver metastases. Kawakatsu S, Mise Y, Hiratsuka M, Inoue Y, Ito H, Takahashi Y, et al. J Surg Oncol. 2020;122(3):523-8.

◆Repeat hepatectomy for liver metastases from bile duct neuroendocrine tumor: a case report. Miyashita M, Ono Y, Takamatsu M, Inoue Y, Sato T, Ito H, et al. Surgical case reports. 2020;6(1):204.

◆Radiologically occult metastatic pancreatic cancer: how can we avoid unbeneficial resection? Oba A, Inoue Y, Ono Y, Irie S, Sato T, Mise Y, et al. Langenbecks Arch Surg. 2020;405(1):35-41.

◆Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion. Oba A, Ito H, Ono Y, Sato T, Mise Y, Inoue Y, et al. BJS open. 2020;4(3):438-48.

◆A multicenter prospective registration study on laparoscopic pancreatectomy in Japan: report on the assessment of 1,429 patients. Ohtsuka T, Nagakawa Y, Toyama H, Takeda Y, Maeda A, Kumamoto Y, et al. J Hepatobiliary Pancreat Sci. 2020;27(2):47-55.

◆Preoperative Biliary Drainage for Patients with Perihilar Bile Duct Malignancy. Takahashi Y, Ito H, Inoue Y, Mise Y, Ono Y, Sato T, et al. J Gastrointest Surg. 2020;24(7):1630-8.

◆Comprehensive comparison of clinicopathological characteristics, treatment, and prognosis of borderline resectable pancreatic cancer according to tumor location. Takeda T, Sasaki T, Inoue Y, Mie T, Furukawa T, Kanata R, et al. Pancreatology. 2020;20(6):1123-30.

◆Early Fistulography Can Predict Whether Biochemical Leakage Develops to Clinically Relevant Postoperative Pancreatic Fistula. Takeda Y, Saiura A, Inoue Y, Mise Y, Ishizawa T, Takahashi Y, et al. World J Surg. 2020;44(4):1252-9.

◆Three-Dimensional Fixation: Pathological Protocol Following Pancreaticoduodenectomy with Portal Vein Resection for Pancreatic Cancer. Tanaka M, Inoue Y, Matsueda K, Hiratsuka M, Muto M, Kawakatsu S, et al. J Gastrointest Surg. 2020;24(3):619-26.

◆Commentary: Complex venous resection and reconstruction for locally advanced pancreatic cancer: Our approach. Ito H, Takahashi Y, Saiura A. Surgery. 2020;168(6):1056-7.

◆High CA19-9 level in resectable pancreatic cancer is a potential indication of neoadjuvant treatment. Ushida Y, Inoue Y, Ito H, Oba A, Mise Y, Ono Y, et al. Pancreatology. 2020.

◆Prognostic significance of regional lymph node metastasis according to station in ampullary carcinoma. Tashiro K, Kuroki N, Einama T, Iwasaki T, Miyata Y, Aosasa S, et al. J Hepatobiliary Pancreat Sci. 2020;27(10):712-20.

◆Global Survey on Pancreatic Surgery During the COVID-19 Pandemic. Oba A, Stoop TF, Löhr M, Hackert T, Zyromski N, Nealon WH, et al. Ann Surg. 2020;272(2):e87-e93.

◆Neoadjuvant Treatment in Pancreatic Cancer. Frontiers in oncology. Oba A, Ho F, Bao QR, Al-Musawi MH, Schulick RD, Del Chiaro M. 2020;10:245.

◆Prognosis Based Definition of Resectability in Pancreatic Cancer: A Road Map to New Guidelines. Oba A, Croce C, Hosokawa P, Meguid C, Torphy RJ, Al-Musawi MH, et al. Ann Surg. 2020.

◆Vascular Resections for Pancreatic Ductal Adenocarcinoma: Vascular Resections for PDAC. Oba A, Bao QR, Barnett CC, Al-Musawi MH, Croce C, Schulick RD, et al. Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society. 2020;109(1):18-28.

◆Conservative drain management increases the incidence of grade B postoperative pancreatic fistula without increasing serious complications: Does persistent drainage reflect the quality of pancreatic surgery or institutional policy?     Takeda Y, Saiura A, Takahashi Y, Inoue Y, Mise Y, Ito H. J Hepatobiliary Pancreat Sci. 2020;27(12):1011-8.

◆Neoadjuvant gemcitabine and nab-paclitaxel for borderline resectable pancreatic cancers: intention-to-treat analysis compared with upfront surgery. Inoue Y, Saiura A, Oba A, Ono Y, Mise Y, Ito H, et al. J Hepatobiliary Pancreat Sci. 2020.

◆Applications of a laparoscopic fluorescence imaging system during open hepatectomy: Tumor/ and segment identification, cholangiography, and angiography. Matsuki R, Ishizawa T, Saiura A. Asian J Endosc Surg. 2020;13(2):256-258.

◆Serum soluble sialic acid-binding immunoglobulin-like lectin-7 concentration as an indicator of liver macrophage activation and advanced fibrosis in patients with non-alcoholic fatty liver disease. Sakamoto Y, Yoshio S, Doi H, Kawai H, Mise Y, Saiura A, et al. Hepatol Res. 2020;50(4):466-477.

◆A Multicenter Phase 2 Trial to Evaluate the Efficacy of mFOLFOX6 + Cetuximab as Induction Chemotherapy to Achieve R0 Surgical Resection for Advanced Colorectal Liver Metastases (NEXTO Trial). Mise Y, Hasegawa K, Saiura A, Oba M, Yamamoto J, Nomura Y, et al. Ann Surg Oncol. 2020;27(11):4188-4195.

●当院でMCNとして診療した46例の検討 MCN疑い病変の経過観察は可能か. 谷口 孝伸, 佐々木 隆, 武田 剛志, 古川 貴光, 井上 陽介, 橋 祐, et al. 膵臓. 2020;35(2):201-12.

●【肝胆膵外科におけるConversion Surgery】切除不能膵癌に対するConversion Surgery 集学的治療の当院成績. 牛田 雄太, 井上 陽介, 笹平 直樹, 中川 茂樹, 三重 尭文, 高橋 祐. 手術. 2020;74(10):1461-9.

●【膵癌診療ガイドライン改訂を外科医はこう読み解く-ディベート&ディスカッション】ディベート 腹腔洗浄細胞診陽性膵癌に対して 切除を行うvs行わない 「切除を行う」の立場から. 牛田 雄太, 井上 陽介, 宮下 真美子, 大庭 篤志, 小野 嘉大, 佐藤 崇文, et al. 臨床外科. 2020;75(6):669-74.

●なぜ手術記録が大切なのか? 肝胆膵外科における手術記事の意義. 井上 陽介, 高橋 祐. 日本消化器外科学会雑誌. 2020;53(10):835-43.

●【膵癌治療の最前線】膵癌手術における上腸間膜動脈周囲の処理. 井上 陽介, 高橋 祐.外科. 2020;82(9):941-8.

<書籍>

2014年

◆がん研スタイル 癌の標準手術 「肝癌」 メディカルビュー社
齋浦明夫ら

2015年

◆がん研スタイル 癌の標準手術 「膵癌・胆道癌」 メディカルビュー社
齋浦明夫ら

◆がん研有明病院の肝臓がん・胆道がん・膵臓がん治療に向きあう食事 女子栄養大学出版部
井上陽介ら

◆Imaging and Visualization in the Modern Operating Room
Chap.22 Fluorescence Imaging of Human Bile and Biliary Anatomy
Springer
Ishizawa T., Kokudo N.

◆Noncolorectal, Nonneuroendocrine Liver Metastasis
Chap.11 Liver Metastasis from Stomach Cancer
Springer
Saiura A.

2016年

◆ICG Fluorescence Imaging and Navigation Surgery
Chap.26 Liver Parenchymal Staining Using Fusion ICG Fluorescence Imaging
Inoue Y., Ishizawa T., Saiura A.

2017年

◆Part IV-19 :Mesopancreas Excision for Pancreatic Cancer 
In: Kim SW, Yamaue H, eds. Pancreatic cancer with special focus on topical issues and surgical techniques. Heiderberg: Springer, 2017, 215-224.
Inoue Y., Saiura A.

◆がん研べからず集(内視鏡手術編): ビデオでみるトラブルシューティング(DVD付)
石沢武彰ら

2018年

◆がん研 肝胆膵外科ビデオワークショップ−ことばと動画で魅せる外科の基本・こだわりの手技
齋浦明夫・石沢武彰・渡邊元己

このページのTOPへ